Stomach Carcinoma  >>  golvatinib (E7050)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
golvatinib (E7050) / Eisai
NCT01355302 / 2011-000774-58: E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer

Terminated
1/2
7
US, Europe, RoW
E7050, cisplatin, capecitabine
Eisai Inc., Quintiles, Inc.
Advanced or Metastatic Solid Tumors, Previously Untreated Gastric Cancer
04/13
07/13

Download Options